4th Quarter - Report

SIDLEY AUSTIN LLP for SUNOVION PHARMACEUTICALS INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 22, 2018 $50,000 Replaced
4th Quarter - Amendment Jan 31, 2018 $50,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Access to prescription drugs and payment/reimbursement related issues, including patient access under Medicare Part D

LobbyistCovered position, as disclosed
LAURA RACHEAL COHEN Intern, Energy & Commerce Committee, Subcommittee on Health
PATRICIA LOUISE DELOATCHE Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, and Legislative Assistant, Rep. Mike Bilirakis
STEPHANIE P HALES N/A
DARON WATTS N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.